Sjogren's Syndrome in Black Women: Symptoms and Diagnosis

Sjogren's syndrome (pronounced SHOW-grins) is an autoimmune disease where white blood cells attack the glands that produce moisture, mainly the tear glands and salivary glands. The hallmark symptoms are dry eyes and dry mouth, but the disease is systemic: it also drives fatigue, joint pain, rapid tooth decay, and in a minority of patients it reaches the nerves, kidneys, and lungs. It affects an estimated 1 to 4 million people in the United States, and women are diagnosed about nine times as often as men.

The two classic signs are dry eyes that burn, itch, or feel gritty like sand, and a dry mouth that makes chewing, swallowing, and tasting harder. Beyond that, the disease reaches well past the glands. The National Institute of Dental and Craniofacial Research lists joint and muscle pain, dry skin, rashes, numbness or tingling in the hands and feet, vaginal dryness, a persistent dry cough, and ongoing fatigue among its effects.

Two symptoms tend to get dismissed. The first is fatigue, which patients often describe as the most disabling part of the disease and which is easy to write off as stress or anemia. The second is dental: when saliva dries up, cavities multiply fast, and adults who never had dental trouble can suddenly need multiple fillings or crowns. Swollen parotid glands, the salivary glands that sit in front of the ears, can make the face look puffy and are a red flag a dentist or doctor should not ignore.

Sjogren's travels in company. It can occur on its own (primary Sjogren's) or alongside another autoimmune disease (secondary Sjogren's), most commonly rheumatoid arthritis, lupus, or Raynaud's phenomenon. That overlap matters for Black women, who already carry a heavier burden of lupus, because dryness symptoms can get folded into an existing diagnosis and never investigated as Sjogren's in their own right.

For most people Sjogren's stays focused on the glands. In a minority it becomes systemic. Peripheral neuropathy, nerve damage that causes numbness, tingling, or burning in the hands and feet, occurs in roughly 6 percent of patients by European rheumatology criteria. The kidneys can develop interstitial nephritis or distal renal tubular acidosis, which throws off potassium and can cause kidney stones. Clinically significant lung involvement, including interstitial lung disease, shows up in an estimated 9 to 20 percent of people with primary Sjogren's.

The complication that drives long-term monitoring is lymphoma. People with primary Sjogren's carry a markedly higher risk of non-Hodgkin lymphoma, especially mucosa-associated lymphoid tissue (MALT) lymphoma. A widely cited Swedish population study found roughly a 16-fold increased risk compared with the general population. The absolute risk for any one person stays low, but it is the reason rheumatologists watch for warning signs like persistent parotid swelling, low complement levels, and certain blood markers.

Honest framing first: there is no reliable, large-scale estimate of how common Sjogren's is specifically among Black Americans. Black patients have been a small slice of the major registries. In the international Big Data Sjogren Project, which analyzed 8,310 patients at diagnosis, Black/African-American patients made up about 1 percent of the cohort. When a population is barely present in the studies, claims about its prevalence are guesses, not data, and we will not invent them.

What the smaller signals suggest is worth flagging without overstating. In the Big Data project, Sjogren's was diagnosed an average of seven years earlier in Black/African-American patients than in white patients. In the Oklahoma Sjogren's research cohort, disease activity scores were not meaningfully different between Black and white patients, but Black patients more often carried markers tied to lymphoma risk: hypergammaglobulinemia (52.6 percent versus 23.6 percent), an elevated ESR (47.1 percent versus 18.4 percent), and parotid gland enlargement. The authors recommended closer surveillance in Black patients. That is a signal from one cohort of 20 Black patients, not a settled fact, and the real gap is research access, not a confirmed prevalence difference.

There is no single test. Diagnosis combines symptoms, blood work, eye and mouth tests, and sometimes a biopsy. The main pieces:

• Antibody blood tests. Anti-SSA/Ro is the key marker and shows up in roughly three-quarters of people with primary Sjogren's; anti-SSB/La is also checked. A negative result does not rule the disease out.
• Schirmer test. A small paper strip placed under the lower eyelid measures how much tears the eye produces over five minutes.
• Lip (minor salivary gland) biopsy. A tiny sample of glands from inside the lower lip is examined for clusters of immune cells. It is required to confirm the diagnosis in people who test negative for anti-SSA/Ro antibodies.

The diagnostic delay is real and well documented. One 2024 cross-sectional study reported a mean time to diagnosis of about six years (median two years), and found that patients who waited longer were in worse overall health and reported more vaginal dryness, gastrointestinal symptoms, and breathlessness by the time they were diagnosed. Much of the lag comes from how scattered the symptoms are and how little the disease is recognized in primary care.

There is no cure, so treatment relieves symptoms and watches for complications. For the eyes, that means artificial tears, lubricating ointments, and prescription drops; for the mouth, frequent water, saliva substitutes, and prescription medicines that stimulate saliva. Aggressive dental care, including fluoride treatments, protects against the rapid decay. Joint pain is treated with anti-inflammatory drugs, and corticosteroids or immunosuppressants are reserved for serious systemic involvement. Ongoing monitoring for kidney, lung, nerve, and lymphoma signs is the part of care that makes a rheumatologist worth seeing.

If your symptoms point to Sjogren's, the right specialist is a rheumatologist; an eye doctor and dentist round out the team. Bring a written list of your dryness, fatigue, and joint symptoms and how long each has lasted, because the timeline is what helps a clinician connect dots that look unrelated in a short visit. You can find a Black rheumatologist or a clinician who serves Black patients through our directory to start with someone who will take your symptoms seriously.